Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Targets & Mechanisms

PureTech plumbs the brain

Why PureTech is targeting brain lymphatics to treat neurodegeneration

July 26, 2018 11:57 PM UTC

PureTech Health plc is backing a new way of thinking about Alzheimer’s disease that positions it primarily as a problem of poor drainage, building on the recent discovery of lymphatic vessels in the brain by Jonathan Kipnis at the University of Virginia.

The company licensed the IP from UVA and will collaborate with the academic group to develop modulators of brain lymphatic vessels. Terms of the deal are undisclosed...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article